By Karen Roman Medical tech company Nano-X Imaging Ltd. (Nasdaq: NNOX) said Nanox.ARC, its digital multi-source 3D ...

In a clinical study, it was found that the Nanox.ARC digital tomosynthesis enhanced musculoskeletal imaging, can improve the sensitivity and ...

CE Mark is the first major regulatory milestone for Nanox.ARC Imaging System in the European market; follows recent general use FDA clearance in ...

PETACH TIKVA, Israel, Feb. 25, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that ...

In a clinical study, it was found that the Nanox.ARC digital tomosynthesis enhanced musculoskeletal imaging, can improve the sensitivity and specificity of conventional radiography. In addition ...

Nanox Imaging Ltd. announced promising results from a clinical study showcasing its Nanox.ARC digital tomosynthesis system, which enhances musculoskeletal imaging and outperforms conventional ...

CE Mark is the first major regulatory milestone for Nanox.ARC Imaging System in the European market; follows recent general use FDA clearance in the U.S. New clinical data supporting use of Nanox ...

Nano-X Imaging shares were up 10%, to $6.61, after the company said it has received CE mark certification to market its multi-source Nanox.ARC system, including the Nanox.CLOUD, its accompanying cloud ...

Nano-X Imaging (NASDAQ:NNOX) received CE mark certification to market the Nanox.ARC system, including the Nanox.CLOUD, its accompanying cloud-based infrastructure.  The company said new clinical data ...